Skip to search formSkip to main contentSkip to account menu

sarpogrelate

Known as: 2-(dimethylamino)-1-((2-(3-methoxyphenyl)phenoxy)methyl)ethyl hydrogensuccinate hydrochloride, mono-(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl)succinate hydrochloride 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (4)

Fibrinolytic AgentsPlatelet Aggregation InhibitorsSerotonin AntagonistsSuccinates

Narrower (1)

MCI 9042

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Cardiovascular remodeling and the peripheral serotonergic system.
Review
2010
Review
2010
Treatment of complex regional pain syndrome: a review of the evidence
Purpose This narrative review summarizes the evidence derived from randomized controlled trials pertaining to the treatment of… 
Highly Cited
2008
Highly Cited
2008
Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A Randomized, Double-Blind, Aspirin-Controlled Trial
Background and Purpose— The antiplatelet agent sarpogrelate is a selective inhibitor of 5-hydroxytryptamine receptors. The… 
Review
2006
Review
2006
Therapeutic potentials of sarpogrelate in cardiovascular disease.
In view of the pivotal role of serotonin (5-HT) in a wide variety of cardiovascular disorders, extensive effort has been made to… 
Highly Cited
2006
Highly Cited
2006
Peripheral 5-HT2A receptor antagonism attenuates primary thermal hyperalgesia and secondary mechanical allodynia after thermal injury in rats
Review
2004
Review
2004
Functions of 5-HT2A receptor and its antagonists in the cardiovascular system.
Highly Cited
2003
Highly Cited
2003
Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats.
Highly Cited
2002
Highly Cited
2002
Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus.
2001
2001
Angiotensin II and serotonin potentiate endothelin-1-induced vascular smooth muscle cell proliferation
2001
2001
Serotonin potentiates angiotensin II--induced vascular smooth muscle cell proliferation.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)